The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
G-CSF Scoping Review Poster presented:
Variation in evaluations of granulocyte colony stimulating factor use: a scoping review of observational studies.
Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.
Nexus 2020 Virtual provides focused, essential learning opportunities starting with a preconference Monday, October 19, followed by a week of programming through Friday, October 23.
